QuantaMatrix

317690 · KOSDAQ · Health Care · SMALL CAP

Revenue up 47.7% in FY2025.

QuantaMatrix reported consolidated results for FY2025: revenue of US$2.46M (+47.7% year on year), an operating loss of US$10.4M and a net loss of US$13M.

Earnings(Change of 30% or more in revenue or profit/loss structure (15% for large companies))· FILED 2026-03-16· RCEPT 20260316901036

US$2.46MRevenue
+47.7%Revenue vs a year earlier
−US$10.4MOperating profit

Converted at 1 USD ≈ ₩1,501.75 (filing-date rate, 2026-03-16 close)

What happened

QuantaMatrix reported consolidated results for FY2025: revenue of US$2.46M (+47.7% year on year), an operating loss of US$10.4M and a net loss of US$13M.

Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.

RevenueUS$2.46M
Revenue vs a year earlier+47.7%
Operating profit−US$10.4M
Net income−US$13M
PeriodFY2025 (consolidated)
Filed2026-03-16, Change of 30% or more in revenue or profit/loss structure (15% for large companies)
SourceDART rcept 20260316901036 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-16 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.